Check out what’s new in food allergy research, including a study on needle-free epinephrine products. Plus, check out our mythbuster on whether trick-or-treat sized candies/chocolates always have the same ingredient list as the full-sized versions.
Research: More developments in needle-free epinephrine products
Aquestive Therapeutics has announced positive results from the EPIPHAST II trial for its AQST-109 product, a sublingual film that can be applied under the tongue for delivery of epinephrine. The EPIPHAST II trial was designed to compare single doses of AQST-109 to EpiPen® 0.3 mg and a generic intramuscular (IM) injection of 0.3 mg of epinephrine. It also compared one and two doses of AQST-109 to that of the epinephrine 0.3 mg IM injection.
“We are pleased to see that AQST-109 compared favorably to both the EpiPen and the epi 0.3 mg IM injection across several measures,” said Daniel Barber, Chief Executive Officer of Aquestive. “This is a meaningful step forward for this program and brings us closer to improving the lives of people who are looking for alternatives to the current standard of care for allergic reactions.”
An end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) is scheduled for the end of this year; remaining clinical studies are expected to begin thereafter. Read their press release for more information.
In last month’s newsletter, we provided information on Bryn Pharma’s UTULY™ epinephrine intranasal spray. This month, we’re sharing news on the AQST-109 epinephrine sublingual film. We’ll continue to keep you updated on needle-free epinephrine products for treatment of anaphylaxis.
Mythbuster – Do trick-or-treat sized candies/chocolates always have the same ingredient list as the full-sized versions?
With Halloween coming up, read our mythbuster on whether trick-or-treat sized candies/chocolates always have the same ingredient list as the full-sized versions.
advocacy, mythbuster, Research